{'fraction_non_alphanumeric': 0.039609993906154786, 'fraction_numerical': 0.020719073735527116, 'mean_word_length': 5.036764705882353, 'pattern_counts': {'":': 0, '<': 2, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Erratum: Statin‐associated changes in skeletal muscle function and stress response after novel or accustomed exercise

FIGURE 3. Plantarflexor fatigability in sedentary, novel exercise, and accustomed exercise groups after 28 days of normal cage activity (Sedentary), 14 days of normal cage activity and 14 days of running wheel access (Novel), or 28 days of running wheel access (Accustomed), with saline or cerivastatin (1 mg/kg) during the final 14 days of treatment. Fatigue was calculated as percent maximal isometric force on the tenth repetition. A significant activity treatment interaction was found for fatigability, with both sed/statin and novel/statin groups showing reduced isometric force on the tenth contraction compared with their respective saline-treated groups. Data expressed as mean þ SE. *P < 0.05 vs. corresponding saline group. FIGURE 4. Average changes in Hsp25 (A) and aB-crystallin (aBC) (B) protein in gastronemius muscles in sedentary, novel exercise, and accustomed exercise groups after 28 days of normal cage activity (sedentary), 14 days of normal cage activity and 14 days running wheel access (Novel), or 28 days of running wheel access (Accustomed), with saline or cerivastatin (1 mg/kg) during the final 14 days of treatment. Representative Western blots for Hsp25 and aB-crystallin for all groups are shown. A significant main effect for activity was found for both Hsps, with significant increases in both novel and accustomed exercise groups. Statin treatment did not significantly affect Hsp expression under any activity condition. Data expressed as mean þ SE. *P < 0.05 vs. non-exercise controls.